Key points are not available for this paper at this time.
Authors
No takes yet. Share an insight, caveat, or question.
RAS expression in oral CSCs is hypothesis-generating; leaves open therapeutic targeting pending functional validation.
Featherston et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: